A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer
Clinical trial NCT06868485 · RECRUITING
Trial details
- NCT number
- NCT06868485
- Sponsor
- Wayshine Biopharm, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-18
- Primary completion
- 2027-09-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.